This project aims to collect detailed clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients at Lung Transplant Centers. The goal is to create a robust resource for various research objectives, including studying the impact of variations in donor and medical practices on clinical outcomes. The project also seeks to identify serum biomarkers associated with or predictive of specific post-transplant complications and conditions.
Able to understand and provide informed consent
≥ 18 years of age at the time of written informed consent
Anticipated listing or listed for a single or bilateral cadaveric donor lung transplant or having received a lung transplant within 30 days
Participants undergoing repeat lung transplantation or multi-organ transplantation are eligible if they meet the inclusion/
Unwillingness of a participant or legally authorized representative (LAR) to give written informed consent or comply with study protocol
Pregnancy or plans to become pregnant
Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
Duke University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
University of Pennsylvania
Collaborator